Jokiranta TS - Search Results

1

Identifying the inheritable component of human thymic T cell repertoire generation in monozygous twins.

Heikkilä N, Vanhanen R, Yohannes DA, Saavalainen P, Meri S, Jokiranta TS, Jarva H, Mattila IP, Hamm D, Sormunen S, Saramäki J, Arstila TP. Heikkilä N, et al. Among authors: jokiranta ts. Eur J Immunol. 2020 May;50(5):748-751. doi: 10.1002/eji.201948404. Epub 2020 Jan 14. Eur J Immunol. 2020. PMID: 31872865 Free article.

2

T cell receptor diversity in the human thymus.

Vanhanen R, Heikkilä N, Aggarwal K, Hamm D, Tarkkila H, Pätilä T, Jokiranta TS, Saramäki J, Arstila TP. Vanhanen R, et al. Among authors: jokiranta ts. Mol Immunol. 2016 Aug;76:116-22. doi: 10.1016/j.molimm.2016.07.002. Epub 2016 Jul 19. Mol Immunol. 2016. PMID: 27442982

3

Complement resistance mechanisms of streptococci.

Jarva H, Jokiranta TS, Würzner R, Meri S. Jarva H, et al. Among authors: jokiranta ts. Mol Immunol. 2003 Sep;40(2-4):95-107. doi: 10.1016/s0161-5890(03)00108-1. Mol Immunol. 2003. PMID: 12914816 Review.

4

Interactions between Bordetella pertussis and the complement inhibitor factor H.

Amdahl H, Jarva H, Haanperä M, Mertsola J, He Q, Jokiranta TS, Meri S. Amdahl H, et al. Among authors: jokiranta ts. Mol Immunol. 2011 Jan;48(4):697-705. doi: 10.1016/j.molimm.2010.11.015. Epub 2010 Dec 16. Mol Immunol. 2011. PMID: 21167605

5

Biotinylation of monoclonal antibodies prevents their ability to activate the classical pathway of complement.

Jokiranta TS, Meri S. Jokiranta TS, et al. J Immunol. 1993 Aug 15;151(4):2124-31. J Immunol. 1993. PMID: 7688394

6

The group B streptococcal beta and pneumococcal Hic proteins are structurally related immune evasion molecules that bind the complement inhibitor factor H in an analogous fashion.

Jarva H, Hellwage J, Jokiranta TS, Lehtinen MJ, Zipfel PF, Meri S. Jarva H, et al. Among authors: jokiranta ts. J Immunol. 2004 Mar 1;172(5):3111-8. doi: 10.4049/jimmunol.172.5.3111. J Immunol. 2004. PMID: 14978117

7

Regulation of complement activation by C-reactive protein: targeting the complement inhibitory activity of factor H by an interaction with short consensus repeat domains 7 and 8-11.

Jarva H, Jokiranta TS, Hellwage J, Zipfel PF, Meri S. Jarva H, et al. Among authors: jokiranta ts. J Immunol. 1999 Oct 1;163(7):3957-62. J Immunol. 1999. PMID: 10490997

8

Exceptional resistance of human H2 glioblastoma cells to complement-mediated killing by expression and utilization of factor H and factor H-like protein 1.

Junnikkala S, Jokiranta TS, Friese MA, Jarva H, Zipfel PF, Meri S. Junnikkala S, et al. Among authors: jokiranta ts. J Immunol. 2000 Jun 1;164(11):6075-81. doi: 10.4049/jimmunol.164.11.6075. J Immunol. 2000. PMID: 10820293

9

Y402H polymorphism of complement factor H affects binding affinity to C-reactive protein.

Laine M, Jarva H, Seitsonen S, Haapasalo K, Lehtinen MJ, Lindeman N, Anderson DH, Johnson PT, Järvelä I, Jokiranta TS, Hageman GS, Immonen I, Meri S. Laine M, et al. Among authors: jokiranta ts. J Immunol. 2007 Mar 15;178(6):3831-6. doi: 10.4049/jimmunol.178.6.3831. J Immunol. 2007. PMID: 17339482 Free PMC article. Clinical Trial.

10

Disturbed sialic acid recognition on endothelial cells and platelets in complement attack causes atypical hemolytic uremic syndrome.

Hyvärinen S, Meri S, Jokiranta TS. Hyvärinen S, et al. Among authors: jokiranta ts. Blood. 2016 Jun 2;127(22):2701-10. doi: 10.1182/blood-2015-11-680009. Epub 2016 Mar 22. Blood. 2016. PMID: 27006390 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

99 results

Search Page